Literature DB >> 11156819

Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation.

M Martinot1, V Bragulat, E Artiges, F Dollé, F Hinnen, R Jouvent, J Martinot.   

Abstract

OBJECTIVE: The study assessed striatal presynaptic dopamine function in patients with different subtypes of depression.
METHOD: Magnetic resonance imaging and positron emission tomography with [(18)F]fluorodopa ([(18)F]DOPA) were used to compare six depressed patients with marked affective flattening and psychomotor retardation, six depressed patients with marked impulsivity and anxiety, and 10 healthy comparison subjects. Depressed patient groups were matched for severity of depression.
RESULTS: [(18)F]DOPA uptake K(i) values in the left caudate were significantly lower in patients with psychomotor retardation than in patients with high impulsivity and in comparison subjects.
CONCLUSIONS: These results suggest that left caudate dopamine function differs between depressed patients with psychomotor retardation and those with impulsivity and provide direct evidence of a link between dopamine hypofunction and psychomotor retardation in depression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156819     DOI: 10.1176/appi.ajp.158.2.314

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  46 in total

Review 1.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

2.  Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies.

Authors:  Paolo Fusar-Poli; Andreas Meyer-Lindenberg
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

Review 3.  Psychomotor retardation in depression: biological underpinnings, measurement, and treatment.

Authors:  Jeylan S Buyukdura; Shawn M McClintock; Paul E Croarkin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-10-31       Impact factor: 5.067

Review 4.  Interoception and Inflammation in Psychiatric Disorders.

Authors:  Jonathan Savitz; Neil A Harrison
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-01-09

5.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

6.  Alcohol withdrawal drives depressive behaviors by activating neurons in the rostromedial tegmental nucleus.

Authors:  Rao Fu; Wanhong Zuo; Nimisha Shiwalkar; Qinghua Mei; Qing Fan; Xuejun Chen; Jing Li; Alex Bekker; Jiang-Hong Ye
Journal:  Neuropsychopharmacology       Date:  2019-03-31       Impact factor: 7.853

7.  Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Daniela Di Giuda; Giovanni Camardese; Anna Rita Bentivoglio; Fabrizio Cocciolillo; Arianna Guidubaldi; Lorella Pucci; Isabella Bruno; Luigi Janiri; Alessandro Giordano; Alfonso Fasano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-14       Impact factor: 9.236

8.  Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study.

Authors:  Charles R Conway; John T Chibnall; Paul Cumming; Mark A Mintun; Marie Anne I Gebara; Dana C Perantie; Joseph L Price; Martha E Cornell; Jonathan E McConathy; Sunil Gangwani; Yvette I Sheline
Journal:  Psychiatry Res       Date:  2014-01-14       Impact factor: 3.222

9.  Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112.

Authors:  Dara M Cannon; Jacqueline M Klaver; Summer A Peck; Denise Rallis-Voak; Kristine Erickson; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2008-10-22       Impact factor: 7.853

10.  Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans.

Authors:  Lena Brydon; Neil A Harrison; Cicely Walker; Andrew Steptoe; Hugo D Critchley
Journal:  Biol Psychiatry       Date:  2008-02-01       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.